Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Operating Expenses | 1,742 | 340 | 0 | 262 | 242 |
| Operating Income | -1,742 | -340 | N/A | -262 | -242 |
| Interest Expense | 51 | 52 | 0 | 30 | 23 |
| Other Income | 0 | 12 | 0 | 0 | 0 |
| Pre-tax Income | -1,792 | -379 | 0 | -293 | -264 |
| Net Income Continuous | -1,792 | -379 | N/A | -293 | -264 |
| Net Income | $-1,792 | $-379 | $N/A | $-293 | $-264 |
| EPS Basic Total Ops | -312.50 | -75.00 | N/A | -56.25 | -50.00 |
| EPS Basic Continuous Ops | -314.93 | -72.47 | N/A | -55.98 | -50.54 |
| EPS Diluted Total Ops | -312.50 | -75.00 | N/A | -56.25 | -50.00 |
| EPS Diluted Continuous Ops | -314.93 | -72.47 | N/A | -55.98 | -50.54 |
| EBITDA(a) | $-1,713 | $-307 | $N/A | $-217 | $-242 |